Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00358735 · ClinicalTrials.gov registry record · NA

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

A NA study of Bleeding and Pulmonary Embolism (PE), sponsored by Medical Compression Systems.

Completed
Registry status
NA
Development phase
411
Enrollment target
9
Study locations

NCT00358735: Completed NA study of Bleeding and Pulmonary Embolism (PE), sponsored by Medical Compression Systems.

NCT00358735 is a NA study of Bleeding and Pulmonary Embolism (PE) that has completed, run by Medical Compression Systems. The registered enrollment target is 411 participants, below the 1,467-participant average among 23 other Bleeding trials with a reported enrollment target (72% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00358735, a NA study of Bleeding and Pulmonary Embolism (PE), has completed, sponsored by Medical Compression Systems.

COMPLETED
Registry status
NA
Development phase
411 participants
Enrollment target
9
Study locations

Study Summary

Evaluation of the safety and effectiveness of ActiveCare+ CECT device +/- baby dose aspirin (81 mg QD) for lowering the potential risk for bleeding and of DVT during and after THA surgery in comparison with LMWH.

Primary Outcome

10-12 days post-op: All of the patients underwent Routine bilateral compression Doppler. Day of surgery and up to 3 months post-op: Suspected clinical signs and symptoms DVT events were confirmed by standard diagnostic objective methods

Conditions Studied

Bleeding Pulmonary Embolism (PE) Deep Vein Thrombosis of Lower Limb

Interventions

  • DRUG Enoxaparin
  • DEVICE ActiveCare CECT device

Study Locations (9)

California

  • Scripps Clinic - La Jolla
  • Empire Orthopedic Center - Loma Linda
  • Cedars-Sinai Medical Center - Los Angeles

Indiana

  • The center for hip and knee surgery - Mooresville

Maryland

  • Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore - Baltimore

Minnesota

  • Mayo Clinic - Rochester

New York

  • Hospital for Special Surgery - New York

Ohio

  • Cleveland Clinic - Cleveland

Oregon

  • The Center Orthopedic & Neurosurgical Care &Research - Bend

Trial Details

FieldValue
Enrollment Target 411 participants
Start Date 2006-06
Est. Completion 2008-12
Phase NA
Medical Compression Systems

2 total trials

What the finished NCT00358735 record still lists

NCT00358735 is an interventional study that assigns participants to a tested intervention. The registered 411 participants enrollment target is mid-sized for trials with a published cap, below the 1,467-participant average among 23 other Bleeding trials with a reported enrollment target (72% lower).

The record links to 3 conditions, with Bleeding appearing as the primary indexed condition, and to 2 interventions - of which Enoxaparin is the first listed.

NCT00358735 lists 9 locations in 7 states (California, Indiana, Maryland).

Frequently Asked Questions

What is clinical trial NCT00358735 about?

NCT00358735 is a clinical study titled "Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)". Evaluation of the safety and effectiveness of ActiveCare+ CECT device +/- baby dose aspirin (81 mg QD) for lowering the potential risk for bleeding and of DVT during and after THA surgery in comparison with LMWH.

What is the current status of trial NCT00358735?

This trial is currently completed. It is a NA study. The enrollment target is 411 participants. The study started on 2006-06. Estimated completion is 2008-12.

What conditions does trial NCT00358735 study?

This clinical trial studies the following conditions: Bleeding, Pulmonary Embolism (PE), Deep Vein Thrombosis of Lower Limb.

What interventions are being tested in trial NCT00358735?

The interventions under investigation include: Enoxaparin (DRUG), ActiveCare CECT device (DEVICE).

Who is sponsoring clinical trial NCT00358735?

This trial is sponsored by Medical Compression Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00358735 being conducted?

This trial has 9 study locations across California, Indiana, Maryland, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bleeding

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00358735's enrollment target sits among peer trials

411 9th of 23 higher than 15 of 23 other Bleeding trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bleeding trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05993689 · 412 participants · NA

    Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE

  • NCT06699212 · 412 participants · Phase 3

    A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

  • NCT02043691 · 410 participants · NA

    Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies

  • NCT03042975 · 410 participants

    Imaging Genetics of Laryngeal Dystonia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00358735, the US trial registry maintained by the National Library of Medicine. NCT00358735 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.